Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Astrazeneca (AZNCF) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for Astrazeneca (AZNCF) over the last 15 years, with Q4 2025 value amounting to 0.0.

  • Astrazeneca's FCF Payout Ratio fell 813.65% to 0.0 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.23, marking a year-over-year increase of 1104.31%. This contributed to the annual value of 0.23 for FY2025, which is 1104.31% up from last year.
  • Astrazeneca's FCF Payout Ratio amounted to 0.0 in Q4 2025, which was down 813.65% from 0.23 recorded in Q3 2025.
  • Over the past 5 years, Astrazeneca's FCF Payout Ratio peaked at 25.45 during Q4 2021, and registered a low of 0.92 during Q1 2021.
  • For the 5-year period, Astrazeneca's FCF Payout Ratio averaged around 1.45, with its median value being 0.28 (2024).
  • In the last 5 years, Astrazeneca's FCF Payout Ratio surged by 6217.45% in 2021 and then crashed by 813.65% in 2025.
  • Over the past 5 years, Astrazeneca's FCF Payout Ratio (Quarter) stood at 25.45 in 2021, then tumbled by 103.01% to 0.77 in 2022, then skyrocketed by 99.06% to 0.01 in 2023, then surged by 91.01% to 0.0 in 2024, then decreased by 8.14% to 0.0 in 2025.
  • Its FCF Payout Ratio was 0.0 in Q4 2025, compared to 0.23 in Q3 2025 and 0.0 in Q2 2025.